ONC
Price
$291.47
Change
-$4.99 (-1.68%)
Updated
Jul 25 closing price
Capitalization
32.77B
11 days until earnings call
ZLAB
Price
$37.17
Change
-$0.60 (-1.59%)
Updated
Jul 25 closing price
Capitalization
4.11B
12 days until earnings call
Interact to see
Advertisement

ONC vs ZLAB

Header iconONC vs ZLAB Comparison
Open Charts ONC vs ZLABBanner chart's image
BeOne Medicines
Price$291.47
Change-$4.99 (-1.68%)
Volume$171.23K
Capitalization32.77B
Zai Lab
Price$37.17
Change-$0.60 (-1.59%)
Volume$638.24K
Capitalization4.11B
ONC vs ZLAB Comparison Chart in %
Loading...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONC vs. ZLAB commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONC is a Buy and ZLAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ONC: $291.47 vs. ZLAB: $37.17)
Brand notoriety: ONC and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONC: 50% vs. ZLAB: 71%
Market capitalization -- ONC: $32.77B vs. ZLAB: $4.11B
ONC [@Biotechnology] is valued at $32.77B. ZLAB’s [@Biotechnology] market capitalization is $4.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONC’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • ONC’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ZLAB is a better buy in the long-term than ONC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONC’s TA Score shows that 5 TA indicator(s) are bullish while ZLAB’s TA Score has 5 bullish TA indicator(s).

  • ONC’s TA Score: 5 bullish, 5 bearish.
  • ZLAB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZLAB is a better buy in the short-term than ONC.

Price Growth

ONC (@Biotechnology) experienced а -1.05% price change this week, while ZLAB (@Biotechnology) price change was +10.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ONC is expected to report earnings on Nov 06, 2025.

ZLAB is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONC($32.8B) has a higher market cap than ZLAB($4.11B). ONC YTD gains are higher at: 57.799 vs. ZLAB (41.924). ONC has higher annual earnings (EBITDA): -116.48M vs. ZLAB (-236.44M). ONC has more cash in the bank: 2.52B vs. ZLAB (757M). ZLAB has less debt than ONC: ZLAB (192M) vs ONC (997M). ONC has higher revenues than ZLAB: ONC (4.18B) vs ZLAB (418M).
ONCZLABONC / ZLAB
Capitalization32.8B4.11B799%
EBITDA-116.48M-236.44M49%
Gain YTD57.79941.924138%
P/E RatioN/AN/A-
Revenue4.18B418M999%
Total Cash2.52B757M332%
Total Debt997M192M519%
FUNDAMENTALS RATINGS
ONC vs ZLAB: Fundamental Ratings
ONC
ZLAB
OUTLOOK RATING
1..100
2017
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9396
PRICE GROWTH RATING
1..100
4040
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLAB's Valuation (48) in the Biotechnology industry is in the same range as ONC (60). This means that ZLAB’s stock grew similarly to ONC’s over the last 12 months.

ONC's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as ZLAB (100). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

ONC's SMR Rating (93) in the Biotechnology industry is in the same range as ZLAB (96). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

ONC's Price Growth Rating (40) in the Biotechnology industry is in the same range as ZLAB (40). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

ONC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ZLAB (100). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ONCZLAB
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
77%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CFO73.070.42
+0.58%
VictoryShares US 500 Enh Vol Wtd ETF
QTEC217.160.54
+0.25%
First Trust NASDAQ-100-Tech Sector ETF
QCJL22.700.04
+0.19%
FT Vest Nasdaq-100 Cnsrv Buffr ETF - Jul
DVAL14.450.02
+0.11%
BrandywineGLOBAL Dyn US Lrg Cap Val ETF
JULJ24.950.02
+0.08%
Innovator Premium Income 30 Bar ETF -Jul

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
-1.68%
ZLAB - ONC
54%
Loosely correlated
-1.59%
MDGL - ONC
42%
Loosely correlated
-0.26%
WXXWY - ONC
37%
Loosely correlated
+4.87%
AXON - ONC
37%
Loosely correlated
+3.63%
GOSS - ONC
35%
Loosely correlated
+3.37%
More